Upfront Anti-CD38 Monoclonal Antibody-Based Quadruplet Therapy for Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials.

Cancers (Basel) · 2025 · PMC12190497 · PMID 40563593

Europe PMC DOI

hedged sentence

0.0400

closest p · 0.8× alpha

0.0400

boldest claim

The sentences

marginally statistically significantp = 0.04actually significant

Moreover, trials focused on high-risk MM patients demonstrated a marginally statistically significant ( p = 0.04) lower PFS rate (79% PFS%, 95% CI: 72–85%) than trials on standard MM populations (87% PFS%, 95% CI: 82–91%) ( Supplementary Table S1 ).

also in 270 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.